News-Medical.Net July 2, 2024
Garvan Institute of Medical Research

Using artificial intelligence, Garvan Institute researchers have found potential cancer drivers hidden in so-called ‘junk’ regions of DNA, opening up possibilities for a new approach to diagnosis and treatment.

Non-coding DNA – the 98% of our genome that doesn’t contain instructions for making proteins – could hold the key to a new approach for diagnosing and treating cancers, according to a new study from the Garvan Institute of Medical Research. The findings, published in the journal Nucleic Acids Research, reveal mutations in previously overlooked regions of the genome that may contribute to the formation and progression of at least 12 different cancers, including prostate, breast and colorectal.

The discovery could lead to early diagnosis and new treatments effective for many...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Pharma / Biotech, Precision Medicine, Survey / Study, Technology, Trends
A Trump 2.0 Agenda For Artificial Intelligence
World Children's Day 2024: Preparing Kids For An AI-Driven Future
Leveraging AI to Reach Occupancy Goals in Senior Living Communities: What You Should Know
8 next big healthcare technologies, per Fast Company
Veritone Introduces Data Refinery, Tackling AI’s Data Drought

Share This Article